Search results for: 'cho l コートフック'
- Product Name
- Organism
- Tag (Tag info)
- Expression Host (Source)
- Did you mean
- chp l コートフック
- ch1 l コートフック
- Related search terms
- Choose either the point or counterpoint to argue for both cases with justification and evidence. Label your choice clearly. C
- Cho hình lăng trụ đứng ABC.A'B'C' có ABC là tam giác vuông cân tại a ab=a cc'=2a khoảng cách giữa aa1 bà bc1
- cho tam giác abc cân tại a ah vuông bc 180-/2
- Cho các hóa chất sau: Ag(NH3)2OH, HCN; Cu(OH)2/OH-, Na; Br2; NaOH, I2/OH-. Trong các điều kiện thích hợp, formaldehyde tác dụng
- chocolate eclair coli white yellow cdna
-
Anti-Human DLL3 (Rovalpituzumab)HumanN/ACHO
Various size from 1 mg to 152 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human FcRn (Batoclimab)HumanN/ACHO
Various size from 1 mg to 153 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human CD137 (Utomilumab)HumanN/ACHO
Various size from 1 mg to 155 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human CD40 (Sotigalimab)HumanN/ACHO
Various size from 1 mg to 156 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human CD47 (Lemzoparlimab)HumanN/ACHO
Various size from 1 mg to 157 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human CD70 (Cusatuzumab)HumanN/ACHO
Various size from 1 mg to 158 mg available. Please inquiry us first for the price and availablity.
-
Anti--human CD79b (Polatuzumab)HumanN/ACHO
Various size from 1 mg to 159 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human FGFR (Aprutumab)HumanN/ACHO
Various size from 1 mg to 160 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human FGFR2 (Bemarituzumab)HumanN/ACHO
Various size from 1 mg to 161 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human GPC3 (Codrituzumab)HumanN/ACHO
Various size from 1 mg to 163 mg available. Please inquiry us first for the price and availablity.